COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications

Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gawałko, Monika, Kapłon-Cieślicka, Agnieszka, Hohl, Mathias, Dobrev, Dobromir, Linz, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462635/
https://www.ncbi.nlm.nih.gov/pubmed/32904969
http://dx.doi.org/10.1016/j.ijcha.2020.100631
_version_ 1783576958651596800
author Gawałko, Monika
Kapłon-Cieślicka, Agnieszka
Hohl, Mathias
Dobrev, Dobromir
Linz, Dominik
author_facet Gawałko, Monika
Kapłon-Cieślicka, Agnieszka
Hohl, Mathias
Dobrev, Dobromir
Linz, Dominik
author_sort Gawałko, Monika
collection PubMed
description Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. Here, we review the available evidence for prevalence and incidence of AF in patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and discuss disease management approaches and potential treatment options for COVID-19 infected AF patients.
format Online
Article
Text
id pubmed-7462635
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-74626352020-09-02 COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications Gawałko, Monika Kapłon-Cieślicka, Agnieszka Hohl, Mathias Dobrev, Dobromir Linz, Dominik Int J Cardiol Heart Vasc Review Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. Here, we review the available evidence for prevalence and incidence of AF in patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and discuss disease management approaches and potential treatment options for COVID-19 infected AF patients. Elsevier 2020-09-01 /pmc/articles/PMC7462635/ /pubmed/32904969 http://dx.doi.org/10.1016/j.ijcha.2020.100631 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Gawałko, Monika
Kapłon-Cieślicka, Agnieszka
Hohl, Mathias
Dobrev, Dobromir
Linz, Dominik
COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
title COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
title_full COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
title_fullStr COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
title_full_unstemmed COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
title_short COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
title_sort covid-19 associated atrial fibrillation: incidence, putative mechanisms and potential clinical implications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462635/
https://www.ncbi.nlm.nih.gov/pubmed/32904969
http://dx.doi.org/10.1016/j.ijcha.2020.100631
work_keys_str_mv AT gawałkomonika covid19associatedatrialfibrillationincidenceputativemechanismsandpotentialclinicalimplications
AT kapłoncieslickaagnieszka covid19associatedatrialfibrillationincidenceputativemechanismsandpotentialclinicalimplications
AT hohlmathias covid19associatedatrialfibrillationincidenceputativemechanismsandpotentialclinicalimplications
AT dobrevdobromir covid19associatedatrialfibrillationincidenceputativemechanismsandpotentialclinicalimplications
AT linzdominik covid19associatedatrialfibrillationincidenceputativemechanismsandpotentialclinicalimplications

Ejemplares similares